Princeton, NJ, United States of America

Jonathan Sporn

This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Sk Biopharmaceuticals Co., Ltd.. Active years: 2013-2025.

USPTO Granted Patents = 8 

% Patents Active = 100.0



Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 198(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations by Jonathan Sporn

Introduction

Jonathan Sporn is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of sleep-wake disorders. With a total of 8 patents to his name, his work has the potential to impact many lives.

Latest Patents

One of his latest patents focuses on the treatment of Excessive Daytime Sleepiness (EDS). This invention outlines a method for administering a therapeutically effective amount of a compound of Formula (I). The compound includes various chemical groups that can be tailored to enhance its effectiveness in treating EDS. The detailed formulation allows for a range of modifications, making it a versatile option for addressing sleep-related issues.

Career Highlights

Throughout his career, Jonathan has worked with several prominent companies, including SK Biopharmaceuticals Co., Ltd. and his own venture, Sporn, Jonathan. His experience in these organizations has contributed to his expertise in developing innovative solutions in the pharmaceutical industry.

Collaborations

Jonathan has collaborated with notable professionals in his field, including Joseph Palumbo and Abdallah Ahnaou. These partnerships have likely enriched his research and development efforts, leading to more effective inventions.

Conclusion

Jonathan Sporn's contributions to the field of sleep-wake disorder treatments exemplify the impact of innovation in healthcare. His patents and collaborations highlight the importance of continued research and development in improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…